J.‐M. Vernejoux

629 total citations
19 papers, 390 citations indexed

About

J.‐M. Vernejoux is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, J.‐M. Vernejoux has authored 19 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in J.‐M. Vernejoux's work include Lung Cancer Research Studies (5 papers), Asthma and respiratory diseases (5 papers) and Lung Cancer Treatments and Mutations (5 papers). J.‐M. Vernejoux is often cited by papers focused on Lung Cancer Research Studies (5 papers), Asthma and respiratory diseases (5 papers) and Lung Cancer Treatments and Mutations (5 papers). J.‐M. Vernejoux collaborates with scholars based in France. J.‐M. Vernejoux's co-authors include V. Latrabe, B. Vergier, J Dubrez, François Laurent, Michel Montaudon, Roger Marthan, Hugues Bégueret, Patrick Berger, José Manuel Tunon-de-Lara and L Dubuisson and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Thorax.

In The Last Decade

J.‐M. Vernejoux

17 papers receiving 378 citations

Peers

Countries citing papers authored by J.‐M. Vernejoux

Since Specialization

Citations

This map shows the geographic impact of J.‐M. Vernejoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐M. Vernejoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐M. Vernejoux more than expected).

Fields of papers citing papers by J.‐M. Vernejoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐M. Vernejoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐M. Vernejoux. The network helps show where J.‐M. Vernejoux may publish in the future.

Co-authorship network of co-authors of J.‐M. Vernejoux

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐M. Vernejoux. A scholar is included among the top collaborators of J.‐M. Vernejoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐M. Vernejoux. J.‐M. Vernejoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6 2010 ·Allergy ·Pierre‐Olivier Girodet, A. Ozier, Thomas Trian, Hugues Bégueret, Olga Ousova, J.‐M. Vernejoux, Pascal Chanez, Roger Marthan, Patrick Berger, Jacinto Lara	43
2	Phase II study of sunitinib in patients with non-small cell lung cancer (NSCLC) and irradiated brain metastases: Final efficacy and safety results. 2010 ·Journal of Clinical Oncology ·Silvia Novello, Carlos Camps, Francesco Grossi, Julien Mazières, Lauren E. Abrey, J.‐M. Vernejoux, Aron D. Thall, Tiziana Usari, Richard C. Chao, Giorgio V. Scagliotti	1
3	Inflammation of bronchial smooth muscle in allergic asthma 2006 ·Thorax ·Hugues Bégueret, Patrick Berger, J.‐M. Vernejoux, L Dubuisson, Roger Marthan, José Manuel Tunon-de-Lara	105
4	Qualité de vie et anxiété-dépression chez les patients atteints de cancer bronchique non à petites cellules (CNPC): impact d’un dispositif d’annonce du diagnostic (DAD) 2006 ·Revue des Maladies Respiratoires ·(unknown), J.‐M. Vernejoux, N. Chakroun, Pierre‐Olivier Girodet, A. Ozier, Michaël Josse, A Taytard	0
5	Développement d’un questionnaire de connaissances sur la BPCO 2005 ·Revue des Maladies Respiratoires ·(unknown), Chantal Rahérison, (unknown), (unknown), J.‐M. Vernejoux, José Manuel Tunon-de-Lara, A Taytard	2
6	P-590 A randomized phase II trial of early change of a chemotherapeuticdoublet versus four cycles of chemotherapy in advanced non small cell lung cancer (NSCLC): Interim analysis of the 03-01 Groupe Français de Pneumo-Cancérologie (GFPC) study 2005 ·Lung Cancer ·A. Vergnenègre, C. Chouaïd, (unknown), (unknown), J.‐M. Vernejoux, (unknown), P. Fournel, D. Arpin, P. David, Pierre‐Marie Preux	0
7	Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin–vinorelbine with a cisplatin–vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study 2002 ·Annals of Oncology ·M. Pérol, H. Léna, P. Thomas, G. Robinet, P. Fournel, (unknown), C. Belleguic, H. Le Caer, F Blanchon, A. Vergnenègre, J.‐M. Vernejoux, (unknown), (unknown)	16
8	Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study 2002 ·Lung Cancer ·P. Thomas, G. Robinet, (unknown), H. Léna, S. Gouva, J.‐M. Vernejoux, J P Kleisbauer	7
9	Detection of circulating cells expressing chromogranin A gene transcripts in patients with lung neuroendocrine carcinoma 2002 ·European Journal of Cancer ·Hugues Bégueret, B. Vergier, J. Bégueret, J.‐M. Vernejoux, Jacques Jougon, R. Trouette, A Taytard, Jean-François Velly, Jean‐Philippe Merlio, A. de Mascarel	5
10	[Does the presence of a pet at home influence the prevalence of asthma and rhinitis?]. 2002 ·PubMed ·(unknown), Chantal Rahérison, J.‐M. Vernejoux, (unknown), A Taytard	5
11	[Sarcoidosis and renal insufficiency]. 2002 ·PubMed ·A. Izadifar, J.‐M. Vernejoux, Chantal Rahérison, (unknown), (unknown), (unknown), V. Latrabe, (unknown), A Taytard	8
12	Spontaneous pneumothorax : pragmatic management and long-term outcome 2001 ·Respiratory Medicine ·J.‐M. Vernejoux, Chantal Rahérison, Pierre Combe, (unknown), Frédéric Laurent, (unknown), A Taytard	13
13	CT-Guided Transthoracic Needle Biopsy of Pulmonary Nodules Smaller than 20 mm: Results with an Automated 20-Gauge Coaxial Cutting Needle 2000 ·Clinical Radiology ·François Laurent, V. Latrabe, B. Vergier, Michel Montaudon, J.‐M. Vernejoux, J Dubrez	157
14	Practical evaluation of asthma exacerbation self-management in children and adolescents 2000 ·Respiratory Medicine ·Chantal Rahérison, J. Manuel Tunon‐de‐Lara, J.‐M. Vernejoux, A Taytard	16
15	[High-dose ifosfamide in patients with stage IV non-small cell lung cancer: phase II trial from the Groupe français de pneumo-cancérologie (GFPC)]. 1999 ·PubMed ·A. Vergnenègre, Paul S. Thomas, G. Robinet, (unknown), D. Paillotin, J.‐M. Vernejoux, Luc Thiberville, H. Léna, (unknown), (unknown)	4
16	[Moderate asthma in adults: diagnosis and management in general medical practice]. 1996 ·PubMed ·J.‐M. Vernejoux, (unknown), Anne‐Valérie Guizard, (unknown), A Taytard	3
17	[Diagnostic and therapeutic strategies in exacerbations of chronic bronchitis in city practice]. 1995 ·PubMed ·A Taytard, J.‐M. Vernejoux, (unknown), Jacinto Lara	1
18	[Presumed transudative pleural effusion?]. 1995 ·PubMed ·Patrick Berger, J.‐M. Vernejoux, (unknown), (unknown), A Taytard	1
19	Salivary IgE in Allergic Patients and Normal Donors 1994 ·International Archives of Allergy and Immunology ·J.‐M. Vernejoux, Jacinto Lara, (unknown), (unknown), A Taytard	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact